MedPath

The effect of polyethylene glycol treatment on gut health in Cystic Fibrosis, a pilot study

Conditions
Cystic Fibrosis
10083624
10015674
10024970
Registration Number
NL-OMON48606
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Cystic fibrosis confirmed by genetic analysis
- Exocrine pancreatic insufficiency as reflected by the use of prescribed
pancreatic enzyme replacement therapy (usually Creon).
- Age of 18 years or above at the time of enrollment in the study

Exclusion Criteria

- A current therapeutic antibiotic course for pulmonary exacerbation or need
for hospitalization for antibiotic treatment (does not include prophylactic
long-term antibiotic use)
- Standard prescribed daily treatment with any laxative at the moment of
inclusion, because it will be undesirable to stop treatment during the washout
period. Occasional treatment with laxatives is not an exclusion criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>change in plasma levels of fibroblast growth factor 19 (FGF19) after 2 weeks of<br /><br>laxative treatment.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Changes in subjective parameters related to intestinal health as measured by<br /><br>the corresponding sections of the validated the cystic fibrosis questionnaire<br /><br>(CF-Q), namely gastrointestinal complaints, general wellbeing/condition and<br /><br>treatment burden.<br /><br><br /><br>- Changes in objective parameters related to intestinal health, among which<br /><br>different metabolic processes:<br /><br>Plasma parameters:<br /><br>o Bile acid metabolism: C4, bile acid profile<br /><br>o Glucose metabolism: (fasted) Glucose, HbA1c, insulin<br /><br>o Liver function: GGT, ASAT, ALAT, thrombocytes, albumin<br /><br>o Cholesterol metabolism: lipoprotein profile, triglycerides<br /><br>o Gut health: glucagon-like peptide 1, serotonin (5-HT)<br /><br>- Faecal parameters:<br /><br>o Microbiota composition<br /><br>o Inflammation: calprotectin, lactoferrin, IgA<br /><br>o Elastase<br /><br>o Neutral sterols</p><br>
© Copyright 2025. All Rights Reserved by MedPath